Cigna Group
Income Statement
| Line Item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $71.67B | $68.49B | $72.47B | $69.75B | $67.18B | $65.50B | $65.65B | $63.69B |
| Cost of Revenue | $56.70B | $54.10B | $57.80B | $55.53B | $53.27B | $48.40B | $49.02B | $47.57B |
| Gross Profit | $14.97B | $14.39B | $14.68B | $14.22B | $13.91B | $17.10B | $16.63B | $16.13B |
| Gross Margin | 20.9% | 21.0% | 20.3% | 20.4% | 20.7% | 26.1% | 25.3% | 25.3% |
| Operating Expenses | ||||||||
| Research & Development | — | — | — | — | — | — | — | — |
| SG&A Expense | $3.47B | $3.72B | $3.61B | $3.36B | $3.43B | $4.21B | $3.87B | $3.59B |
| Operating Income | $2.68B | $2.36B | $2.35B | $2.58B | $2.31B | $1.97B | $2.17B | $2.58B |
| Operating Margin | 3.7% | 3.4% | 3.2% | 3.7% | 3.4% | 3.0% | 3.3% | 4.0% |
| Interest Expense | $359.0M | $357.0M | $337.0M | $363.0M | $338.0M | $362.0M | $373.0M | $380.0M |
| Pretax Income | $2.26B | $2.27B | $1.82B | $2.30B | $2.02B | $1.65B | $2.01B | $1.19B |
| Income Tax Expense | $382.0M | $409.0M | $543.0M | $322.0M | $389.0M | $239.0M | $473.0M | $367.0M |
| Net Income | $1.66B | $1.65B | $1.13B | $1.97B | $1.53B | $1.32B | $1.19B | $825.0M |
| Net Margin | 2.3% | 2.4% | 1.6% | 2.8% | 2.3% | 2.0% | 1.8% | 1.3% |
| EPS (Basic) | $6.31 | $6.30 | $4.67 | $7.02 | $5.76 | $4.88 | $5.06 | $2.65 |
| EPS (Diluted) | $6.29 | $6.26 | $4.64 | $6.98 | $5.71 | $4.85 | $5.01 | $2.63 |
| Shares Outstanding (Basic) | — | — | — | — | — | — | — | — |
| Shares Outstanding (Diluted) | 264.0M | 264.0M | 268.6M | 267.5M | 268.2M | 273.0M | 283.2M | 281.4M |
| Dividends Per Share | $1.56 | $1.56 | $1.51 | $1.51 | $1.51 | $1.51 | $1.40 | $1.40 |